The rationale for the treatment of long-Covid symptoms - A cardiologist's view

Elisabeth Schieffer1, Bernhard Schieffer1

  • 1Department of Cardiology, Angiology and Critical Care Medicine, University Hospital Marburg (UKGM), Philipps University Marburg, Marburg, Germany.

Insights

Post-acute sequelae of COVID-19 (long-Covid) and rare post-vaccination symptoms share overlapping conditions. A unified therapeutic strategy is needed as both SARS-CoV-2 infection and spike protein vaccination may trigger similar inflammatory responses.

Area of Science:

  • Immunology
  • Neurology
  • Cardiovascular Medicine
  • Psychiatry

Background:

  • The COVID-19 pandemic has resulted in numerous cases of long-term health issues, collectively known as post-acute sequelae of COVID-19 (long-Covid).
  • These debilitating symptoms affect neurological, cardiovascular, and psychiatric functions.
  • Rare instances of similar symptoms have also been observed following SARS-CoV-2 vaccination, suggesting a common underlying mechanism.

Approach:

  • This research highlights the shared symptomatology between long-Covid and post-vaccination syndromes.
  • It emphasizes the role of the SARS-CoV-2 spike protein in potentially triggering these conditions, whether through natural infection or vaccination.
  • The study advocates for a comprehensive therapeutic approach addressing both post-viral and post-vaccination sequelae.

Key Points:

  • Long-Covid symptoms encompass a wide range of neurological, cardiovascular, and psychiatric disorders.
  • Post-vaccination symptoms, though rare, exhibit significant overlap with canonical long-Covid symptoms.
  • Exposure to the SARS-CoV-2 spike protein, via infection or vaccination, may initiate identical immuno-inflammatory pathways.

Conclusions:

  • A unified therapeutic strategy is crucial for managing both post-SARS-CoV-2 infection and post-vaccination long-term symptoms.
  • Understanding the shared immuno-inflammatory cascades is key to developing effective treatments.
  • Further research is warranted to explore therapeutic interventions targeting these common pathways.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19